Rockwell Medical (RMTI) Gross Profit Growth (3y) (2013 - 2026)
Rockwell Medical (RMTI) Gross Profit Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | 6.23% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | 3.42% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | -0.01% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 8.70% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | -3.26% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 28.48% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 8.60% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Rockwell Medical | 29.81 Mn | 5.01 Mn | 3.24 Mn | 46.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 46.43% |
| Mar 31, 2026 | 3.68% |
| Dec 31, 2025 | 18.34% |
| Sep 30, 2025 | 43.00% |
| Jun 30, 2025 | 12.78% |
| Mar 31, 2025 | 80.39% |
| Dec 31, 2024 | 53.65% |
| Sep 30, 2024 | 175.73% |
| Jun 30, 2024 | 168.54% |
| Mar 31, 2024 | 96.96% |
| Dec 31, 2023 | 95.35% |
| Sep 30, 2023 | 85.32% |
| Jun 30, 2023 | 5.45% |
| Mar 31, 2023 | 32.67% |
| Dec 31, 2022 | 28.15% |
| Sep 30, 2022 | 262.68% |
| Jun 30, 2022 | 33.52% |
| Mar 31, 2022 | -40.57% |
| Dec 31, 2021 | -57.19% |
| Sep 30, 2021 | -29.41% |